Market Reports Center

Global RNAi for Therapeutic Market Size, Status and Forecast 2019-2025


Report Details

Global RNAi for Therapeutic Market Size, Status and Forecast 2019-2025

SKU QYFEB281930
Category Life Sciences
Publisher QY Research
Pages 96
Published Feb-19
Request Discount Pay by Wire/Invoice

Description

RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.
RNAi for Therapeutic is in the development stage and there is no use in the market. The fastest research is Clinical phrase III, Such as QP1-1007, QO1-1002 of Quark Pharmaceuticals. The major technology of RNAi for Therapeutic is siRNA, miRNA and shRNA. SiRNA technology is the most popular, with the expenses market share of 85%, following SiRNA, miRNA is the second of 16% expenses market share in 2015.
At present, global expenses concentrates in US and Europe, US takes 80% market share and Europe takes 5% market share. There is A Few R & D Company in the world and the market concentration is high. The top5 (expenses in RNAi for Therapeutic) companies are Alnylam Pharmaceuticals, Arrowhead, Dicerna Pharmaceuticals, Gradalis, miRagen Therapeutics. The five companies occupy about 83% of the market share.
In 2018, the global RNAi for Therapeutic market size was 990 million US$ and it is expected to reach 5200 million US$ by the end of 2025, with a CAGR of 23.1% during 2019-2025.

This report focuses on the global RNAi for Therapeutic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the RNAi for Therapeutic development in United States, Europe and China.

The key players covered in this study
Alnylam Pharmaceuticals
Arbutus Biopharma (Tekmira)
Arrowhead
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
Silence Therapeutics
Benitec Biopharma
miRagen Therapeutics
Sylentis
Gradalis
Sirnaomics
Silenseed

Market segment by Type, the product can be split into
siRNA
miRNA
shRNA

Market segment by Application, split into
Cancer
Cardiovascular
HBV
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global RNAi for Therapeutic status, future forecast, growth opportunity, key market and key players.
To present the RNAi for Therapeutic development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of RNAi for Therapeutic are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


News/Press Release

Table of Content

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global RNAi for Therapeutic Market Size Growth Rate by Type (2014-2025)
1.4.2 siRNA
1.4.3 miRNA
1.4.4 shRNA
1.5 Market by Application
1.5.1 Global RNAi for Therapeutic Market Share by Application (2014-2025)
1.5.2 Cancer
1.5.3 Cardiovascular
1.5.4 HBV
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 RNAi for Therapeutic Market Size
2.2 RNAi for Therapeutic Growth Trends by Regions
2.2.1 RNAi for Therapeutic Market Size by Regions (2014-2025)
2.2.2 RNAi for Therapeutic Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 RNAi for Therapeutic Market Size by Manufacturers
3.1.1 Global RNAi for Therapeutic Revenue by Manufacturers (2014-2019)
3.1.2 Global RNAi for Therapeutic Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global RNAi for Therapeutic Market Concentration Ratio (CR5 and HHI)
3.2 RNAi for Therapeutic Key Players Head office and Area Served
3.3 Key Players RNAi for Therapeutic Product/Solution/Service
3.4 Date of Enter into RNAi for Therapeutic Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global RNAi for Therapeutic Market Size by Type (2014-2019)
4.2 Global RNAi for Therapeutic Market Size by Application (2014-2019)

5 United States
5.1 United States RNAi for Therapeutic Market Size (2014-2019)
5.2 RNAi for Therapeutic Key Players in United States
5.3 United States RNAi for Therapeutic Market Size by Type
5.4 United States RNAi for Therapeutic Market Size by Application

6 Europe
6.1 Europe RNAi for Therapeutic Market Size (2014-2019)
6.2 RNAi for Therapeutic Key Players in Europe
6.3 Europe RNAi for Therapeutic Market Size by Type
6.4 Europe RNAi for Therapeutic Market Size by Application

7 China
7.1 China RNAi for Therapeutic Market Size (2014-2019)
7.2 RNAi for Therapeutic Key Players in China
7.3 China RNAi for Therapeutic Market Size by Type
7.4 China RNAi for Therapeutic Market Size by Application

8 Japan
8.1 Japan RNAi for Therapeutic Market Size (2014-2019)
8.2 RNAi for Therapeutic Key Players in Japan
8.3 Japan RNAi for Therapeutic Market Size by Type
8.4 Japan RNAi for Therapeutic Market Size by Application

9 Southeast Asia
9.1 Southeast Asia RNAi for Therapeutic Market Size (2014-2019)
9.2 RNAi for Therapeutic Key Players in Southeast Asia
9.3 Southeast Asia RNAi for Therapeutic Market Size by Type
9.4 Southeast Asia RNAi for Therapeutic Market Size by Application

10 India
10.1 India RNAi for Therapeutic Market Size (2014-2019)
10.2 RNAi for Therapeutic Key Players in India
10.3 India RNAi for Therapeutic Market Size by Type
10.4 India RNAi for Therapeutic Market Size by Application

11 Central & South America
11.1 Central & South America RNAi for Therapeutic Market Size (2014-2019)
11.2 RNAi for Therapeutic Key Players in Central & South America
11.3 Central & South America RNAi for Therapeutic Market Size by Type
11.4 Central & South America RNAi for Therapeutic Market Size by Application

12 International Players Profiles
12.1 Alnylam Pharmaceuticals
12.1.1 Alnylam Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 RNAi for Therapeutic Introduction
12.1.4 Alnylam Pharmaceuticals Revenue in RNAi for Therapeutic Business (2014-2019)
12.1.5 Alnylam Pharmaceuticals Recent Development
12.2 Arbutus Biopharma (Tekmira)
12.2.1 Arbutus Biopharma (Tekmira) Company Details
12.2.2 Company Description and Business Overview
12.2.3 RNAi for Therapeutic Introduction
12.2.4 Arbutus Biopharma (Tekmira) Revenue in RNAi for Therapeutic Business (2014-2019)
12.2.5 Arbutus Biopharma (Tekmira) Recent Development
12.3 Arrowhead
12.3.1 Arrowhead Company Details
12.3.2 Company Description and Business Overview
12.3.3 RNAi for Therapeutic Introduction
12.3.4 Arrowhead Revenue in RNAi for Therapeutic Business (2014-2019)
12.3.5 Arrowhead Recent Development
12.4 Dicerna Pharmaceuticals
12.4.1 Dicerna Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 RNAi for Therapeutic Introduction
12.4.4 Dicerna Pharmaceuticals Revenue in RNAi for Therapeutic Business (2014-2019)
12.4.5 Dicerna Pharmaceuticals Recent Development
12.5 Mirna Therapeutics
12.5.1 Mirna Therapeutics Company Details
12.5.2 Company Description and Business Overview
12.5.3 RNAi for Therapeutic Introduction
12.5.4 Mirna Therapeutics Revenue in RNAi for Therapeutic Business (2014-2019)
12.5.5 Mirna Therapeutics Recent Development
12.6 Quark Pharmaceuticals
12.6.1 Quark Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 RNAi for Therapeutic Introduction
12.6.4 Quark Pharmaceuticals Revenue in RNAi for Therapeutic Business (2014-2019)
12.6.5 Quark Pharmaceuticals Recent Development
12.7 RXi Pharmaceuticals
12.7.1 RXi Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 RNAi for Therapeutic Introduction
12.7.4 RXi Pharmaceuticals Revenue in RNAi for Therapeutic Business (2014-2019)
12.7.5 RXi Pharmaceuticals Recent Development
12.8 Silence Therapeutics
12.8.1 Silence Therapeutics Company Details
12.8.2 Company Description and Business Overview
12.8.3 RNAi for Therapeutic Introduction
12.8.4 Silence Therapeutics Revenue in RNAi for Therapeutic Business (2014-2019)
12.8.5 Silence Therapeutics Recent Development
12.9 Benitec Biopharma
12.9.1 Benitec Biopharma Company Details
12.9.2 Company Description and Business Overview
12.9.3 RNAi for Therapeutic Introduction
12.9.4 Benitec Biopharma Revenue in RNAi for Therapeutic Business (2014-2019)
12.9.5 Benitec Biopharma Recent Development
12.10 miRagen Therapeutics
12.10.1 miRagen Therapeutics Company Details
12.10.2 Company Description and Business Overview
12.10.3 RNAi for Therapeutic Introduction
12.10.4 miRagen Therapeutics Revenue in RNAi for Therapeutic Business (2014-2019)
12.10.5 miRagen Therapeutics Recent Development
12.11 Sylentis
12.12 Gradalis
12.13 Sirnaomics
12.14 Silenseed

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Figures

List of Tables and Figures

Table RNAi for Therapeutic Key Market Segments
Table Key Players RNAi for Therapeutic Covered
Table Global RNAi for Therapeutic Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global RNAi for Therapeutic Market Size Market Share by Type 2014-2025
Figure siRNA Figures
Table Key Players of siRNA
Figure miRNA Figures
Table Key Players of miRNA
Figure shRNA Figures
Table Key Players of shRNA
Table Global RNAi for Therapeutic Market Size Growth by Application 2014-2025 (Million US$)
Figure Cancer Case Studies
Figure Cardiovascular Case Studies
Figure HBV Case Studies
Figure Other Case Studies
Figure RNAi for Therapeutic Report Years Considered
Table Global RNAi for Therapeutic Market Size 2014-2025 (Million US$)
Figure Global RNAi for Therapeutic Market Size and Growth Rate 2014-2025 (Million US$)
Table Global RNAi for Therapeutic Market Size by Regions 2014-2025 (Million US$)
Table Global RNAi for Therapeutic Market Size by Regions 2014-2019 (Million US$)
Table Global RNAi for Therapeutic Market Share by Regions 2014-2019
Figure Global RNAi for Therapeutic Market Share by Regions 2014-2019
Figure Global RNAi for Therapeutic Market Share by Regions 2019
Table Market Top Trends
Table Global RNAi for Therapeutic Revenue by Manufacturers (2014-2019) (Million US$)
Table Global RNAi for Therapeutic Market Share by Manufacturers (2014-2019)
Figure Global RNAi for Therapeutic Market Share by Manufacturers in 2018
Table Global RNAi for Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players RNAi for Therapeutic Product/Solution/Service
Table Date of Enter into RNAi for Therapeutic Market
Table Mergers & Acquisitions, Expansion Plans
Table Global RNAi for Therapeutic Market Size by Type (2014-2019) (Million US$)
Table Global RNAi for Therapeutic Market Size Share by Type (2014-2019)
Figure Global RNAi for Therapeutic Market Size Market Share by Type (2014-2019)
Table Global RNAi for Therapeutic Market Size by Application (2014-2019) (Million US$)
Table Global RNAi for Therapeutic Market Size Share by Application (2014-2019)
Figure Global RNAi for Therapeutic Market Size Market Share by Application (2014-2019)
Figure Global RNAi for Therapeutic Revenue Market Share by Application in 2018
Figure United States RNAi for Therapeutic Market Size 2014-2019 (Million US$)
Table United States Key Players RNAi for Therapeutic Revenue (2018-2019) (Million US$)
Table United States Key Players RNAi for Therapeutic Market Share (2018-2019)
Table United States RNAi for Therapeutic Market Size by Type (2014-2019) (Million US$)
Table United States RNAi for Therapeutic Market Share by Type (2014-2019)
Table United States RNAi for Therapeutic Market Size by Application (2014-2019) (Million US$)
Table United States RNAi for Therapeutic Market Share by Application (2014-2019)
Figure Europe RNAi for Therapeutic Market Size 2014-2019 (Million US$)
Table Europe Key Players RNAi for Therapeutic Revenue (2018-2019) (Million US$)
Table Europe Key Players RNAi for Therapeutic Market Share (2018-2019)
Table Europe RNAi for Therapeutic Market Size by Type (2014-2019) (Million US$)
Table Europe RNAi for Therapeutic Market Share by Type (2014-2019)
Table Europe RNAi for Therapeutic Market Size by Application (2014-2019) (Million US$)
Table Europe RNAi for Therapeutic Market Share by Application (2014-2019)
Figure China RNAi for Therapeutic Market Size 2014-2019 (Million US$)
Table China Key Players RNAi for Therapeutic Revenue (2018-2019) (Million US$)
Table China Key Players RNAi for Therapeutic Market Share (2018-2019)
Table China RNAi for Therapeutic Market Size by Type (2014-20189) (Million US$)
Table China RNAi for Therapeutic Market Share by Type (2014-2019)
Table China RNAi for Therapeutic Market Size by Application (2014-2019) (Million US$)
Table China RNAi for Therapeutic Market Share by Application (2014-2019)
Figure Japan RNAi for Therapeutic Market Size 2014-2019 (Million US$)
Table Japan Key Players RNAi for Therapeutic Revenue (2018-2019) (Million US$)
Table Japan Key Players RNAi for Therapeutic Market Share (2018-2019)
Table Japan RNAi for Therapeutic Market Size by Type (2014-2019) (Million US$)
Table Japan RNAi for Therapeutic Market Share by Type (2014-2019)
Table Japan RNAi for Therapeutic Market Size by Application (2014-2019) (Million US$)
Table Japan RNAi for Therapeutic Market Share by Application (2014-2019)
Figure Southeast Asia RNAi for Therapeutic Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players RNAi for Therapeutic Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players RNAi for Therapeutic Market Share (2018-2019)
Table Southeast Asia RNAi for Therapeutic Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia RNAi for Therapeutic Market Share by Type (2014-2019)
Table Southeast Asia RNAi for Therapeutic Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia RNAi for Therapeutic Market Share by Application (2014-2019)
Figure India RNAi for Therapeutic Market Size 2014-2019 (Million US$)
Table India Key Players RNAi for Therapeutic Revenue (2018-2019) (Million US$)
Table India Key Players RNAi for Therapeutic Market Share (2018-2019)
Table India RNAi for Therapeutic Market Size by Type (2014-2019) (Million US$)
Table India RNAi for Therapeutic Market Share by Type (2014-2019)
Table India RNAi for Therapeutic Market Size by Application (2014-2019) (Million US$)
Table India RNAi for Therapeutic Market Share by Application (2014-2019)
Figure Central & South America RNAi for Therapeutic Market Size 2014-2019 (Million US$)
Table Central & South America Key Players RNAi for Therapeutic Revenue (2018-2019) (Million US$)
Table Central & South America Key Players RNAi for Therapeutic Market Share (2018-2019)
Table Central & South America RNAi for Therapeutic Market Size by Type (2014-2019) (Million US$)
Table Central & South America RNAi for Therapeutic Market Share by Type (2014-2019)
Table Central & South America RNAi for Therapeutic Market Size by Application (2014-2019) (Million US$)
Table Central & South America RNAi for Therapeutic Market Share by Application (2014-2019)
Table Alnylam Pharmaceuticals Company Details
Table Alnylam Pharmaceuticals Revenue in RNAi for Therapeutic Business (2014-2019) (Million US$)
Figure Alnylam Pharmaceuticals Revenue Growth Rate in RNAi for Therapeutic Business (2014-2019)
Table Alnylam Pharmaceuticals Recent Development
Table Arbutus Biopharma (Tekmira) Company Details
Table Arbutus Biopharma (Tekmira) Revenue in RNAi for Therapeutic Business (2014-2019)(Million US$)
Figure Arbutus Biopharma (Tekmira) Revenue Growth Rate in RNAi for Therapeutic Business (2014-2019)
Table Arbutus Biopharma (Tekmira) Recent Development
Table Arrowhead Company Details
Table Arrowhead Revenue in RNAi for Therapeutic Business (2014-2019)(Million US$)
Figure Arrowhead Revenue Growth Rate in RNAi for Therapeutic Business (2014-2019)
Table Arrowhead Recent Development
Table Dicerna Pharmaceuticals Company Details
Table Dicerna Pharmaceuticals Revenue in RNAi for Therapeutic Business (2014-2019)(Million US$)
Figure Dicerna Pharmaceuticals Revenue Growth Rate in RNAi for Therapeutic Business (2014-2019)
Table Dicerna Pharmaceuticals Recent Development
Table Mirna Therapeutics Company Details
Table Mirna Therapeutics Revenue in RNAi for Therapeutic Business (2014-2019)(Million US$)
Figure Mirna Therapeutics Revenue Growth Rate in RNAi for Therapeutic Business (2014-2019)
Table Mirna Therapeutics Recent Development
Table Quark Pharmaceuticals Company Details
Table Quark Pharmaceuticals Revenue in RNAi for Therapeutic Business (2014-2019)(Million US$)
Figure Quark Pharmaceuticals Revenue Growth Rate in RNAi for Therapeutic Business (2014-2019)
Table Quark Pharmaceuticals Recent Development
Table RXi Pharmaceuticals Company Details
Table RXi Pharmaceuticals Revenue in RNAi for Therapeutic Business (2014-2019)(Million US$)
Figure RXi Pharmaceuticals Revenue Growth Rate in RNAi for Therapeutic Business (2014-2019)
Table RXi Pharmaceuticals Recent Development
Table Silence Therapeutics Company Details
Table Silence Therapeutics Revenue in RNAi for Therapeutic Business (2014-2019)(Million US$)
Figure Silence Therapeutics Revenue Growth Rate in RNAi for Therapeutic Business (2014-2019)
Table Silence Therapeutics Recent Development
Table Benitec Biopharma Company Details
Table Benitec Biopharma Revenue in RNAi for Therapeutic Business (2014-2019)(Million US$)
Figure Benitec Biopharma Revenue Growth Rate in RNAi for Therapeutic Business (2014-2019)
Table Benitec Biopharma Recent Development
Table miRagen Therapeutics Company Details
Table miRagen Therapeutics Revenue in RNAi for Therapeutic Business (2014-2019)(Million US$)
Figure miRagen Therapeutics Revenue Growth Rate in RNAi for Therapeutic Business (2014-2019)
Table miRagen Therapeutics Recent Development
Table Sylentis Company Details
Table Gradalis Company Details
Table Sirnaomics Company Details
Table Silenseed Company Details
Table Global RNAi for Therapeutic Market Size by Regions (Million US$) 2019-2025
Figure Global RNAi for Therapeutic Market Size Share by Regions (2019-2025)
Figure Global RNAi for Therapeutic Market Size Share by Regions in 2025
Figure United States RNAi for Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure Europe RNAi for Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure China RNAi for Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure Japan RNAi for Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia RNAi for Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure India RNAi for Therapeutic Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America RNAi for Therapeutic Market Size Forecast (2019-2025)(Million USD)
Table Global RNAi for Therapeutic Market Size by Product (2019-2025) (Million US$)
Figure Global RNAi for Therapeutic Market Size by Product (2019-2025)
Figure Global RNAi for Therapeutic Market Size by Product in 2025
Table Global RNAi for Therapeutic Market Size by Application (2019-2025) (Million US$)
Figure Global RNAi for Therapeutic Market Size by Application (2019-2025)
Figure Global RNAi for Therapeutic Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Market Reports Center © Copyright 2019 All rights reserved.

wire transfer
HDFC
ssl